Replies to post #31222 on ViaDerma Inc (VDRM)

[running high]

Thanks retired early, I’m looking forward to the ride on both of them. You think we will also see dollars with VDRM.

[zombywolf]

Wasnt the Japan business supposed to generate at $12 million in earnings in 2018? If so, I calculated a share price of around 50 cents:

$12,000,000 x 40%= $4,800,000 net earnings

$4,800,000/436,000,000 shares= .011 earnings per share

$.011 x 40 P/E= .44 share price

Add a couple cents for some more over $12 mil and should be at .50

Now the big question is can VDRM hit a buck in SP? Would take over
$25 million in earnings to do so. A $1 SP would have a cap of $436 million. Doesnt seem to be out of line in comparison to other bio's when they ran earlier in the year if they hit those earnings. O hit around $450 mil in cap then with nothing to sell. For me, O has to hit $4 to generate the same return as here for $1. $4 for them seems like a no brainer, $1 here seems doable, but less than a no brainer, because of transparency issues and that stupid court case by Keough. JMO of course.